Skip to Main Content

Author Details

Maria A Doyle
Peter MacCallum Cancer Centre
2007
39
24
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36622853Galaxy Training: A powerful framework for teaching!PLoS Comput Biol2023
37188662Spatial analysis with SPIAT and spaSim to characterize and simulate tissue microenvironments.Nat Commun2023
34028547Interfacing Seurat with the R tidy universe.Bioinformatics2021
33482892tidybulk: an R tidy framework for modular transcriptomic data analysis.Genome Biol2021
33782609User-friendly, scalable tools and workflows for single-cell RNA-seq analysis.Nat Methods2021
33835453RNA-Seq Data Analysis in Galaxy.Methods Mol Biol2021
32357859Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei.BMC Cancer2020
33079170A single-cell RNA-sequencing training and analysis suite using the Galaxy framework.Gigascience2020
32917631CDK13 cooperates with CDK12 to control global RNA polymerase II processivity.Sci Adv2020
32698852Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours.BMC Res Notes2020
30843206Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma.J Pathol2019
31073612The RNA workbench 2.0: next generation RNA data analysis.Nucleic Acids Res2019
28262675Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene.Nat Commun2017
28438193PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratories.Genome Med2017
28081715Erratum to: Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors.Genome Med2017
27374225Id2 and E Proteins Orchestrate the Initiation and Maintenance of MLL-Rearranged Acute Myeloid Leukemia.Cancer Cell2016
26017449Whole-genome characterization of chemoresistant ovarian cancer.Nature2015
26506417Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes.Oncotarget2015
26503049Corrigendum: Whole-genome characterization of chemoresistant ovarian cancer.Nature2015
26257827Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors.Genome Med2015
26283626Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls.Breast Cancer Res2015
26231170Loss of heterozygosity: what is it good for?BMC Med Genomics2015
24870132Studying cancer genomics through next-generation DNA sequencing and bioinformatics.Methods Mol Biol2014
24752294Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: a virtual appliance approach for instant deployment.PLoS One2014
24813887The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.Cell Rep2014
23096461RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary.J Pathol2013
24073752A simple consensus approach improves somatic mutation prediction accuracy.Genome Med2013
24030150Preclinical screening of histone deacetylase inhibitors combined with ABT-737, rhTRAIL/MD5-1 or 5-azacytidine using syngeneic Vk*MYC multiple myeloma.Cell Death Dis2013
22474122CONTRA: copy number analysis for targeted resequencing.Bioinformatics2012
23028338Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.PLoS Genet2012
22536442MicroRNA genes and their target 3'-untranslated regions are infrequently somatically mutated in ovarian cancers.PLoS One2012
22147957Next-generation sequencing for cancer diagnostics: a practical perspective.Clin Biochem Rev2011
20361874Drug target prediction and prioritization: using orthology to predict essentiality in parasite genomes.BMC Genomics2010
20808766Identification of attractive drug targets in neglected-disease pathogens using an in silico approach.PLoS Negl Trop Dis2010
20485481Massively parallel sequencing and analysis of the Necator americanus transcriptome.PLoS Negl Trop Dis2010
20158936Central carbon metabolism of Leishmania parasites.Parasitology2010
19497128LeishCyc: a biochemical pathways database for Leishmania major.BMC Syst Biol2009
18927591Genomic-scale prioritization of drug targets: the TDR Targets database.Nat Rev Drug Discov2008
17697791Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis.Growth Horm IGF Res2007
  • 1 - 39 of 39

Recommended Authors

Daniel H??bschmann
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)
Career Start Year 2016
Number of shared co-authors 0
Marta Gut
Universitat de Barcelona (UB)
Career Start Year 2010
Number of shared co-authors 6
Chandra Sekhar Pedamallu
Broad Institute
Career Start Year 2009
Number of shared co-authors 2
Cyriac Kandoth
University of California los angeles
Career Start Year 2008
Number of shared co-authors 5
Ken Chen
University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Mark J Cowley
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 8
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 5
Jeroen de Ridder
Center for Molecular Medicine, University Medical Center Utrecht
Career Start Year 2006
Number of shared co-authors 1
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 2
Han Liang
MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
Yongjun Zhao
Canada British Columbia Cancer Research Centre, University of British Columbia
Career Start Year 2005
Number of shared co-authors 6
Semin Lee
Ulsan National Institute of Science and Technology (UNIST)
Career Start Year 2005
Number of shared co-authors 4
Matthias Schlesner
University of Augsburg
Career Start Year 2004
Number of shared co-authors 4
Matthew D Wilkerson
Uniformed Services University of the Health Sciences
Career Start Year 2004
Number of shared co-authors 1
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 10
Malachi Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 2
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 0
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 3
Osvaldo Gra??a
Spanish National Cancer Research Centre-CNIO
Career Start Year 2002
Number of shared co-authors 1
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 1
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 1
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 9
Quang M Trinh
Ontario Institute for Cancer Research
Career Start Year 1999
Number of shared co-authors 1
Nuria Lopez-Bigas
Universitat Pompeu Fabra
Career Start Year 1999
Number of shared co-authors 10
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 5
Steven J M Jones
University of British Columbia
Career Start Year 1995
Number of shared co-authors 10
Marco A Marra
University of British Columbia
Career Start Year 1993
Number of shared co-authors 12
Jean-Pierre A Kocher
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 0
Elaine R Mardis
The Ohio State University
Career Start Year 1988
Number of shared co-authors 2
David A Wheeler
Baylor College of Medicine
Career Start Year 1984
Number of shared co-authors 11

Collaborators

Ian G Campbell
Co-authored papers 14
Kylie L Gorringe
Co-authored papers 11
Georgina L Ryland
Co-authored papers 10
David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers 9
Anthony T Papenfuss
Co-authored papers 5
Ricky W Johnstone
The University of Melbourne
Co-authored papers 5
David Y H Choong
Co-authored papers 4
Stuart A Ralph
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne
Co-authored papers 4
Yoke-Eng Chiew
Westmead Hospital
Co-authored papers 3
Heather Thorne
Peter MacCallum Cancer Centre
Co-authored papers 3
Anna DeFazio
Westmead Hospital
Co-authored papers 3
Eric S Rasche
Clinical Bioinformatics Group, Erasmus Medical Center
Co-authored papers 2
Irene Papatheodorou
Co-authored papers 2
Sian Fereday
Peter MacCallum Cancer Centre
Co-authored papers 2
Matthew Berriman
Wellcome Sanger Institute
Co-authored papers 2
Ronny Drapkin
University of Pennsylvania School of Medicine
Co-authored papers 2
Nicola Waddell
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Santiago J Carmona
AGORA Cancer Research Center
Co-authored papers 2
Katia Nones
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Dhanasekaran Shanmugam
CSIR - National Chemical Laboratory
Co-authored papers 2
Sean M Grimmond
The University of Melbourne
Co-authored papers 2
Euan A Stronach
Imperial College London
Co-authored papers 2
Nadia Traficante
Peter MacCallum Cancer Centre
Co-authored papers 2
Wesley C Van Voorhis
Center for Emerging and Re-emerging Infectious Diseases, University of Washington
Co-authored papers 2
Robert Brown
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers 2
Joy Hendley
Peter MacCallum Cancer Centre
Co-authored papers 2
Peter Leif Bergsagel
Co-authored papers 2
Gareth P Gregory
School of Clinical Sciences at Monash Health, Monash University
Co-authored papers 2
George Au-Yeung
The University of Melbourne
Co-authored papers 2
Christiane Hertz-Fowler
Institute of Integrative Biology, University of Liverpool
Co-authored papers 2
Release 1.2